Follow
Anujan Ramesh
Anujan Ramesh
Post Doctoral Fellow
Verified email at seas.harvard.edu - Homepage
Title
Cited by
Cited by
Year
A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer
A Kulkarni, V Chandrasekar, SK Natarajan, A Ramesh, P Pandey, ...
Nature biomedical engineering 2 (8), 589-599, 2018
1612018
CSF1R‐and SHP2‐inhibitor‐loaded nanoparticles enhance cytotoxic activity and phagocytosis in tumor‐associated macrophages
A Ramesh, S Kumar, D Nandi, A Kulkarni
Advanced Materials 31 (51), 1904364, 2019
1542019
A Nitric Oxide (NO) Nanoreporter for Noninvasive Real‐Time Imaging of Macrophage Immunotherapy
A Ramesh, S Kumar, A Brouillard, D Nandi, A Kulkarni
Advanced Materials 32 (24), 2000648, 2020
672020
Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy
A Ramesh, A Brouillard, S Kumar, D Nandi, A Kulkarni
Biomaterials 227, 119559, 2020
672020
Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy
A Nguyen, A Ramesh, S Kumar, D Nandi, A Brouillard, A Wells, ...
Science advances 6 (40), eabc2777, 2020
502020
Targeting macrophages: a novel avenue for cancer drug discovery
S Kumar, A Ramesh, A Kulkarni
Expert Opinion on Drug Discovery 15 (5), 561-574, 2020
322020
Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy
A Ramesh, S Kumar, A Nguyen, A Brouillard, A Kulkarni
Nanoscale 12 (3), 1875-1885, 2020
262020
Dual inhibitors-loaded nanotherapeutics that target kinase signaling pathways synergize with immune checkpoint inhibitor
A Ramesh, SK Natarajan, D Nandi, A Kulkarni
Cellular and Molecular Bioengineering 12, 357-373, 2019
152019
Supramolecular nanotherapeutics enable metabolic reprogramming of tumor‐associated macrophages to inhibit tumor growth
A Ramesh, V Malik, A Brouillard, A Kulkarni
Journal of Biomedical Materials Research Part A 110 (8), 1448-1459, 2022
112022
Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor–loaded nanoparticle enhances anticancer efficacy
A Ramesh, V Malik, HA Ranjani, H Smith, AA Kulkarni
Drug Delivery and Translational Research 11 (6), 2317-2327, 2021
102021
TLR7/8 agonist and SHP2 inhibitor loaded nanoparticle enhances macrophage immunotherapy efficacy
V Malik, A Ramesh, AA Kulkarni
Advanced Therapeutics 4 (8), 2100086, 2021
82021
Supramolecular polysaccharide nanotheranostics that inhibit cancer cells growth and monitor targeted therapy response
N Deshpande, A Ramesh, D Nandi, A Nguyen, A Brouillard, A Kulkarni
Nanotheranostics 4 (3), 156, 2020
82020
Supramolecular nanotherapeutics for macrophage immunotherapy
A Ramesh, A Brouillard, A Kulkarni
ACS Applied Bio Materials 4 (6), 4653-4666, 2021
72021
A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer. Nat Biomed Eng. 2018; 2 (8): 589–99
A Kulkarni, V Chandrasekar, SK Natarajan, A Ramesh, P Pandey, ...
7
Protein Corona formation on lipid nanoparticles negatively affects the NLRP3 inflammasome activation
M Debnath, J Forster III, A Ramesh, A Kulkarni
Bioconjugate chemistry 34 (10), 1766-1779, 2023
52023
Nanoreporter for Real‐Time Monitoring of Inflammasome Activity and Targeted Therapy
D Nandi, J Forster III, A Ramesh, A Nguyen, H Bharadwaj, A Kulkarni
Advanced Science 10 (6), 2204900, 2023
32023
Delivery strategies for reprogramming tumor-associated macrophages
A Ramesh, AA Kulkarni
Systemic Drug Delivery Strategies, 83-115, 2022
22022
Activatable Nanoreporters for Real‐Time Tracking of Macrophage Phenotypic States Associated with Disease Progression
A Ramesh, N Deshpande, V Malik, A Nguyen, M Malhotra, M Debnath, ...
Small 19 (41), 2300978, 2023
12023
Caspase-1 Responsive Nanoreporter for In Vivo Monitoring of Inflammasome Immunotherapy
D Nandi, J Forster III, A Ramesh, A Nguyen, H Bharadwaj, A Kulkarni
ACS Applied Materials & Interfaces 15 (48), 55545-55558, 2023
2023
Protein Corona Formation on Lipid Nanoparticles Affects the NLRP3 Inflammasome
M Debnath, J Forster III, A Ramesh, A Kulkarni
2023 AIChE Annual Meeting, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20